Wingli-M Tablet 1/250mg
Composition
One tablet(1/250mg) contains :
Glimepiride · · · · · · 1mg
Metformin hydrochloride · · · · · · 250mg
Indication
As an adjunct to diet and exercise in NIDDM (type 2) patients
* In case that the monotherapy with sulfonylurea or metformin does not result in adequate glycemic control
* Replacement of combination therapy of sulfonylurea and metformin
Dosage & Administration
1 to 2 tablets daily
Presentation
30 tablets / bottle
<img src="http://www.bestmadeinkorea.com/photo/2015/jc/Wingli-M-Tablet-1250mg.jpg" alt="Wingli-M-Tablet-1250mg.jpg" >
Share Wingli-M Tablet 1/250mg in Social Media